NCT06838195View on ClinicalTrials.gov

Clinical Trial of the S. Flexneri-S. Sonnei Bivalent Conjugate Vaccine

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

8,000

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

July 2, 2028

Study Completion Date

July 30, 2028

Conditions
DysenteryDysentery, Shigella
Interventions
BIOLOGICAL

S. Flexneri-S. Sonnei bivalent conjugate vaccine

Subjects receive two doses of the vaccine on the day of randomisation (day 0) and day 30.

BIOLOGICAL

Placebo

Subjects receive two doses of the placebo on the day of randomisation (day 0) and day 30.

Trial Locations (1)

1216

Icddr,B, Dhaka

All Listed Sponsors
lead

Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

INDUSTRY